April 27, 2009
Generating Evidence to Guide Merger Enforcement
Orley Ashenfelter, Daniel Hosken, Matthew Weinberg, Apr 30, 2009 The challenge of effective merger enforcement is tremendous. U.S. antitrust agencies must, by statute, quickly forecast the competitive effects of mergers...
February 24, 2009
The Undetected Elephant in the Room: An Analysis of DG...
This article is part of a Chronicle. See more from this Chronicle Anthony Dawes, James Killick, Feb 24, 2009 On November 28, 2008, DG Competition’s (“DG COMP”) published its Preliminary...
February 24, 2009
The Interplay of Patenting Strategies and Competition Law in the...
This article is part of a Chronicle. See more from this Chronicle Kristina Nordlander, Stephen Spinks, Feb 24, 2009 In the presentation of its Preliminary Report on the pharmaceutical sector...
November 11, 2008
The EC’s Investigation into the Pharmaceutical Sector: Trouble Ahead at...
This article is part of a Chronicle. See more from this Chronicle David Hull, Nov 12, 2008 Efforts by innovative pharmaceutical companies to protect their markets against generic drugs have...
November 11, 2008
The 2008 EC Sector Inquiry Regarding Pharmaceuticals: What Does It...
This article is part of a Chronicle. See more from this Chronicle Kent Bernard, Nov 12, 2008 A sector inquiry is never pleasant for the sector involved. It is much...
October 30, 2008
Schumpeterian Competition and Antitrust
Herbert Hovenkamp, Nov 01, 2008 Joseph Schumpeter´s vision of competition saw it as a destructive process in which effort, assets, and fortunes were continuously destroyed by innovation. This endless process...
October 21, 2008
The Justice Department’s Section 2 Report: In Search of A...
This article is part of a Chronicle. See more from this Chronicle Joseph Angland, Oct 1, 2008 A key element in a claim for actual or attempted monopolization is that...
October 01, 2008
Oct-08(1)
In this issue: The DOJ’s Section 2 Report & Single Firm Conduct Report William Kolasky, Oct 1, 2008 The Justice Department’s Section 2 Report: The Widening Schism on Pennsylvania Ave....
July 17, 2008
Innovation Markets after Genzyme/Novazyme
This article is part of a Chronicle. See more from this Chronicle Richard Gilbert, Jul 12, 2008 The U.S. Federal Trade Commission alleged adverse effects on innovation in about forty...